Skip to main content
NCBI home page
Anesthesia Progress logoLink to Anesthesia Progress
. 1988 May-Jun;35(3):87–101.

Principles of Pharmacotherapy: I. Pharmacodynamics

Thomas J Pallasch
PMCID: PMC2168027  PMID: 3046440

Abstract

This paper and the ensuing series present the principles guiding and affecting the ability of drugs to produce therapeutic benefit or untoward harm. The principles of pharmacodynamics and pharmacokinetics, the physiologic basis of adverse drug reactions and suitable antidotal therapy, and the biologic basis of drug allergy, drug-drug interactions, pharmacogenetics, teratology and hematologic reactions to chemicals are explored. These principles serve to guide those administering and using drugs to attain the maximum benefit and least attendant harm from their use. Such is the goal of rational therapeutics.

Full text

PDF
87

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ariëns E. J. Intrinsic activity: partial agonists and partial antagonists. J Cardiovasc Pharmacol. 1983;5 (Suppl 1):S8–15. [PubMed] [Google Scholar]
  2. Ariëns E. J. Receptors: perspectives in pathology and clinical medicine. J Recept Res. 1984;4(1-6):1–17. doi: 10.3109/10799898409042536. [DOI] [PubMed] [Google Scholar]
  3. BEECHER H. K. The powerful placebo. J Am Med Assoc. 1955 Dec 24;159(17):1602–1606. doi: 10.1001/jama.1955.02960340022006. [DOI] [PubMed] [Google Scholar]
  4. Barnett A., Iorio L. C., Billard W. Novel receptor specificity of selected benzodiazepines. Clin Neuropharmacol. 1985;8 (Suppl 1):S8–16. doi: 10.1097/00002826-198508001-00003. [DOI] [PubMed] [Google Scholar]
  5. Bender A. D. Pharmacodynamic principles of drug therapy in the aged. J Am Geriatr Soc. 1974 Jul;22(7):296–303. doi: 10.1111/j.1532-5415.1974.tb05397.x. [DOI] [PubMed] [Google Scholar]
  6. Bergman S. A. The benzodiazepine receptor. Anesth Prog. 1986 Sep-Oct;33(5):213–219. [PMC free article] [PubMed] [Google Scholar]
  7. Black J. L., Richelson E., Richardson J. W. Antipsychotic agents: a clinical update. Mayo Clin Proc. 1985 Nov;60(11):777–789. doi: 10.1016/s0025-6196(12)60421-2. [DOI] [PubMed] [Google Scholar]
  8. Brachman P. S., Dan B. B., Haley R. W., Hooton T. M., Garner J. S., Allen J. R. Nosocomial surgical infections: incidence and cost. Surg Clin North Am. 1980 Feb;60(1):15–25. doi: 10.1016/s0039-6109(16)42030-x. [DOI] [PubMed] [Google Scholar]
  9. Brockhouse R. T. Malignant hyperthermia. J Am Dent Assoc. 1979 Apr;98(4):581–583. doi: 10.14219/jada.archive.1979.0084. [DOI] [PubMed] [Google Scholar]
  10. Bush P. J. The placebo effect. J Am Pharm Assoc. 1974 Dec;14(12):671–674. doi: 10.1016/s0003-0465(16)35011-x. [DOI] [PubMed] [Google Scholar]
  11. Conney A. H., Coutinho C., Koechlin B., Swarm R., Cheripko J. A., Impellizzeri C., Baruth H. From animals to man: metabolic considerations. Clin Pharmacol Ther. 1974 Jul;16(1):176–182. doi: 10.1002/cpt1974161part2176. [DOI] [PubMed] [Google Scholar]
  12. Dedrick R. L., Bischoff K. B. Species similarities in pharmacokinetics. Fed Proc. 1980 Jan;39(1):54–59. [PubMed] [Google Scholar]
  13. Dixon R. E. Effect of infections on hospital care. Ann Intern Med. 1978 Nov;89(5 Pt 2 Suppl):749–753. doi: 10.7326/0003-4819-89-5-749. [DOI] [PubMed] [Google Scholar]
  14. Friedhoff A. J., Miller J. C. Clinical implications of receptor sensitivity modification. Annu Rev Neurosci. 1983;6:121–148. doi: 10.1146/annurev.ne.06.030183.001005. [DOI] [PubMed] [Google Scholar]
  15. Garattini S. Toxic effects of chemicals: difficulties in extrapolating data from animals to man. Crit Rev Toxicol. 1985;16(1):1–29. doi: 10.3109/10408448509041323. [DOI] [PubMed] [Google Scholar]
  16. Goodwin J. S., Goodwin J. M., Vogel A. V. Knowledge and use of placebos by house officers and nurses. Ann Intern Med. 1979 Jul;91(1):106–110. doi: 10.7326/0003-4819-91-1-106. [DOI] [PubMed] [Google Scholar]
  17. Hofer P., Scollo-Lavizzari G. Benzodiazepine antagonist Ro 15-1788 in self-poisoning. Diagnostic and therapeutic use. Arch Intern Med. 1985 Apr;145(4):663–664. [PubMed] [Google Scholar]
  18. Hollister L. E. Prescribing drugs for the elderly. Geriatrics. 1977 Aug;32(8):71–73. [PubMed] [Google Scholar]
  19. Hurwitz N. Predisposing factors in adverse reactions to drugs. Br Med J. 1969 Mar 1;1(5643):536–539. doi: 10.1136/bmj.1.5643.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kalow W. Ethnic differences in drug metabolism. Clin Pharmacokinet. 1982 Sep-Oct;7(5):373–400. doi: 10.2165/00003088-198207050-00001. [DOI] [PubMed] [Google Scholar]
  21. Kitchen I. Endogenous opioid nomenclature: light at the end of the tunnel. Gen Pharmacol. 1985;16(2):79–84. doi: 10.1016/0306-3623(85)90040-0. [DOI] [PubMed] [Google Scholar]
  22. Labella F. S. The general anesthesia receptor. Perspect Biol Med. 1982 Winter;25(2):322–331. doi: 10.1353/pbm.1982.0051. [DOI] [PubMed] [Google Scholar]
  23. Lasagna L. The placebo effect. J Allergy Clin Immunol. 1986 Jul;78(1 Pt 2):161–165. doi: 10.1016/0091-6749(86)90008-4. [DOI] [PubMed] [Google Scholar]
  24. Martin W. R., Eades C. G., Thompson J. A., Huppler R. E., Gilbert P. E. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther. 1976 Jun;197(3):517–532. [PubMed] [Google Scholar]
  25. Marx J. L. A new view of receptor action. Science. 1984 Apr 20;224(4646):271–274. doi: 10.1126/science.6143399. [DOI] [PubMed] [Google Scholar]
  26. McCabe R. T., Wamsley J. K. Autoradiographic localization of subcomponents of the macromolecular GABA receptor complex. Life Sci. 1986 Nov 24;39(21):1937–1945. doi: 10.1016/0024-3205(86)90317-6. [DOI] [PubMed] [Google Scholar]
  27. Miller L. G., Greenblatt D. J., Shader R. I. Benzodiazepine receptor binding: influence of physiologic and pharmacologic factors. Biopharm Drug Dispos. 1987 Mar-Apr;8(2):103–114. doi: 10.1002/bdd.2510080202. [DOI] [PubMed] [Google Scholar]
  28. Notes on the package insert. JAMA. 1969 Feb 17;207(7):1335–1338. [PubMed] [Google Scholar]
  29. Ouslander J. G. Drug therapy in the elderly. Ann Intern Med. 1981 Dec;95(6):711–722. doi: 10.7326/0003-4819-95-6-711. [DOI] [PubMed] [Google Scholar]
  30. Pallasch T. J. A critique of antibiotic prophylaxis. CDA J. 1986 May;14(5):28–36. [PubMed] [Google Scholar]
  31. Pallasch T. J. Antibiotics: past, present, and future. CDA J. 1986 May;14(5):65–68. [PubMed] [Google Scholar]
  32. Pallasch T. J., Gill C. J. Butorphanol and nalbuphine: a pharmacologic comparison. Oral Surg Oral Med Oral Pathol. 1985 Jan;59(1):15–20. doi: 10.1016/0030-4220(85)90108-2. [DOI] [PubMed] [Google Scholar]
  33. Piafsky K. M. Disease-induced changes in the plasma binding of basic drugs. Clin Pharmacokinet. 1980 May-Jun;5(3):246–262. doi: 10.2165/00003088-198005030-00004. [DOI] [PubMed] [Google Scholar]
  34. Rane A., Wilson J. T. Clinical pharmacokinetics in infants and children. Clin Pharmacokinet. 1976;1(1):2–24. doi: 10.2165/00003088-197601010-00002. [DOI] [PubMed] [Google Scholar]
  35. Reidenberg M. M. Kidney function and drug action. N Engl J Med. 1985 Sep 26;313(13):816–818. doi: 10.1056/NEJM198509263131309. [DOI] [PubMed] [Google Scholar]
  36. Richards J. G., Möhler H. Benzodiazepine receptors. Neuropharmacology. 1984 Feb;23(2B):233–242. doi: 10.1016/0028-3908(84)90064-9. [DOI] [PubMed] [Google Scholar]
  37. Rikans L. E. Drugs and nutrition in old age. Life Sci. 1986 Sep 22;39(12):1027–1036. doi: 10.1016/0024-3205(86)90193-1. [DOI] [PubMed] [Google Scholar]
  38. Ritchie J. M. A pharmacological approach to the structure of sodium channels in myelinated axons. Annu Rev Neurosci. 1979;2:341–362. doi: 10.1146/annurev.ne.02.030179.002013. [DOI] [PubMed] [Google Scholar]
  39. Roth S. H. Mechanisms of anaesthesia: a review. Can Anaesth Soc J. 1980 Sep;27(5):433–439. doi: 10.1007/BF03007039. [DOI] [PubMed] [Google Scholar]
  40. Sanvordeker D. R., Lambert H. J. Environmental modification of mammalian drug metabolism and biological response. Drug Metab Rev. 1974;3(2):201–229. doi: 10.3109/03602537408993743. [DOI] [PubMed] [Google Scholar]
  41. Schmucker D. L. Aging and drug disposition: an update. Pharmacol Rev. 1985 Jun;37(2):133–148. [PubMed] [Google Scholar]
  42. Stock J. G., Strunin L. Unexplained hepatitis following halothane. Anesthesiology. 1985 Oct;63(4):424–439. doi: 10.1097/00000542-198510000-00014. [DOI] [PubMed] [Google Scholar]
  43. Strichartz G. R. Current concepts of the mechanism of action of local anesthetics. J Dent Res. 1981 Aug;60(8):1460–1470. doi: 10.1177/00220345810600080904. [DOI] [PubMed] [Google Scholar]
  44. Tallman J. F., Gallager D. W. The GABA-ergic system: a locus of benzodiazepine action. Annu Rev Neurosci. 1985;8:21–44. doi: 10.1146/annurev.ne.08.030185.000321. [DOI] [PubMed] [Google Scholar]
  45. Tallman J. F., Paul S. M., Skolnick P., Gallager D. W. Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science. 1980 Jan 18;207(4428):274–281. doi: 10.1126/science.6101294. [DOI] [PubMed] [Google Scholar]
  46. Verbeeck R. K., Branch R. A., Wilkinson G. R. Drug metabolites in renal failure: pharmacokinetic and clinical implications. Clin Pharmacokinet. 1981 Sep-Oct;6(5):329–345. doi: 10.2165/00003088-198106050-00001. [DOI] [PubMed] [Google Scholar]
  47. Vesell E. S. Complex effects of diet on drug disposition. Clin Pharmacol Ther. 1984 Sep;36(3):285–296. doi: 10.1038/clpt.1984.177. [DOI] [PubMed] [Google Scholar]
  48. WOLF S. The pharmacology of placebos. Pharmacol Rev. 1959 Dec;11:689–704. [PubMed] [Google Scholar]
  49. Williams R. L. Drug administration in hepatic disease. N Engl J Med. 1983 Dec 29;309(26):1616–1622. doi: 10.1056/NEJM198312293092605. [DOI] [PubMed] [Google Scholar]
  50. Williams R. L., Mamelok R. D. Hepatic disease and drug pharmacokinetics. Clin Pharmacokinet. 1980 Nov-Dec;5(6):528–547. doi: 10.2165/00003088-198005060-00002. [DOI] [PubMed] [Google Scholar]

Articles from Anesthesia Progress are provided here courtesy of American Dental Society of Anesthesiology

RESOURCES